129 related articles for article (PubMed ID: 23845032)
1. Intracellular and extracellular Hsp70 chaperone as a target for cancer therapy.
Guzhova IV; Shevtsov MA; Abkin SV; Pankratova KM; Margulis BA
Int J Hyperthermia; 2013 Aug; 29(5):399-408. PubMed ID: 23845032
[TBL] [Abstract][Full Text] [Related]
2. The 'peptidome' of tumour-derived chaperone-rich cell lysate anti-cancer vaccines reveals potential tumour antigens that stimulate tumour immunity.
Graner MW; Romanoski A; Katsanis E
Int J Hyperthermia; 2013 Aug; 29(5):380-9. PubMed ID: 23725202
[TBL] [Abstract][Full Text] [Related]
3. Message in a bottle: role of the 70-kDa heat shock protein family in anti-tumor immunity.
Calderwood SK; Theriault JR; Gong J
Eur J Immunol; 2005 Sep; 35(9):2518-27. PubMed ID: 16144035
[TBL] [Abstract][Full Text] [Related]
4. Heat shock protein derivatives for delivery of antigens to antigen presenting cells.
Nishikawa M; Takemoto S; Takakura Y
Int J Pharm; 2008 Apr; 354(1-2):23-7. PubMed ID: 17980980
[TBL] [Abstract][Full Text] [Related]
5. Dual role of heat shock proteins as regulators of apoptosis and innate immunity.
Joly AL; Wettstein G; Mignot G; Ghiringhelli F; Garrido C
J Innate Immun; 2010; 2(3):238-47. PubMed ID: 20375559
[TBL] [Abstract][Full Text] [Related]
6. Generation of anti-tumor immunity using mammalian heat shock protein 70 DNA vaccines for cancer immunotherapy.
Li Y; Subjeck J; Yang G; Repasky E; Wang XY
Vaccine; 2006 Jun; 24(25):5360-70. PubMed ID: 16714072
[TBL] [Abstract][Full Text] [Related]
7. [Hsp70 chaperone and the prospects of its application in anticancer therapy].
Guzhova IV; Novoselov SS; Margulis BA
Tsitologiia; 2005; 47(3):187-99. PubMed ID: 16706162
[TBL] [Abstract][Full Text] [Related]
8. [Dual role of chaperones in the response of a cell and of a whole organism to stress].
Margulis BA; Guzhova IV
Tsitologiia; 2009; 51(3):219-28. PubMed ID: 19435276
[TBL] [Abstract][Full Text] [Related]
9. Heat shock protein 70: role in antigen presentation and immune stimulation.
Milani V; Noessner E; Ghose S; Kuppner M; Ahrens B; Scharner A; Gastpar R; Issels RD
Int J Hyperthermia; 2002; 18(6):563-75. PubMed ID: 12537755
[TBL] [Abstract][Full Text] [Related]
10. Hsp70, a messenger from hyperthermia for the immune system.
Jolesch A; Elmer K; Bendz H; Issels RD; Noessner E
Eur J Cell Biol; 2012 Jan; 91(1):48-52. PubMed ID: 21458102
[TBL] [Abstract][Full Text] [Related]
11. Immunostimulatory functions of membrane-bound and exported heat shock protein 70.
Radons J; Multhoff G
Exerc Immunol Rev; 2005; 11():17-33. PubMed ID: 16385841
[TBL] [Abstract][Full Text] [Related]
12. How is the immune response affected by hyperthermia and heat shock proteins?
Calderwood SK; Theriault JR; Gong J
Int J Hyperthermia; 2005 Dec; 21(8):713-6. PubMed ID: 16338853
[TBL] [Abstract][Full Text] [Related]
13. Hsp70 chaperone as a survival factor in cell pathology.
Guzhova I; Margulis B
Int Rev Cytol; 2006; 254():101-49. PubMed ID: 17147998
[TBL] [Abstract][Full Text] [Related]
14. Potent tumor-specific immunity induced by an in vivo heat shock protein-suicide gene-based tumor vaccine.
Ren W; Strube R; Zhang X; Chen SY; Huang XF
Cancer Res; 2004 Sep; 64(18):6645-51. PubMed ID: 15374979
[TBL] [Abstract][Full Text] [Related]
15. A novel DNA vaccine constructed by heat shock protein 70 and melanoma antigen-encoding gene 3 against tumorigenesis.
Qu P; Ma JH; Zhang XM; Huang XJ; Yang XW; Yan-Fang S
Indian J Exp Biol; 2010 May; 48(5):436-43. PubMed ID: 20795360
[TBL] [Abstract][Full Text] [Related]
16. Genetically modified tumour vaccines--where we are today.
Nawrocki S; Mackiewicz A
Cancer Treat Rev; 1999 Feb; 25(1):29-46. PubMed ID: 10212588
[TBL] [Abstract][Full Text] [Related]
17. Cellular and molecular chaperone fusion vaccines: targeting resistant cancer cell populations.
Calderwood SK; Gong J; Stevenson MA; Murshid A
Int J Hyperthermia; 2013 Aug; 29(5):376-9. PubMed ID: 23682824
[TBL] [Abstract][Full Text] [Related]
18. Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy.
Schmitt E; Gehrmann M; Brunet M; Multhoff G; Garrido C
J Leukoc Biol; 2007 Jan; 81(1):15-27. PubMed ID: 16931602
[TBL] [Abstract][Full Text] [Related]
19. Heat shock protein-antigen fusions lose their enhanced immunostimulatory capacity after endotoxin depletion.
Marincek BC; Kühnle MC; Srokowski C; Schild H; Hämmerling G; Momburg F
Mol Immunol; 2008 Nov; 46(1):181-91. PubMed ID: 18804283
[TBL] [Abstract][Full Text] [Related]
20. [Regulation of human dendrite cells' physiological functions with the recombinant heat shock protein Hsp70].
Pal'tsev MA; Severin SE; Danilevskiĭ MI; Moskaleva EIu
Ross Fiziol Zh Im I M Sechenova; 2009 Oct; 95(10):1011-23. PubMed ID: 19957893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
